BSE Live
Oct 27, 16:01Prev. Close
176.90
Open Price
176.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 27, 15:59Prev. Close
176.70
Open Price
178.00
Bid Price (Qty.)
178.13 (1312)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.40 | 6.92 | 6.41 | 4.51 | 5.76 | |
| Diluted EPS (Rs.) | 8.40 | 6.92 | 6.41 | 4.51 | 5.76 | |
| Cash EPS (Rs.) | 10.28 | 8.59 | 7.00 | 5.66 | 6.71 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 54.44 | 46.03 | 38.95 | 29.88 | 22.12 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 54.44 | 46.03 | 38.95 | 29.88 | 22.12 | |
| Revenue from Operations/Share (Rs.) | 57.88 | 48.05 | 40.87 | 36.42 | 33.62 | |
| PBDIT/Share (Rs.) | 13.22 | 11.23 | 8.80 | 7.35 | 8.46 | |
| PBIT/Share (Rs.) | 11.38 | 9.59 | 7.65 | 6.25 | 7.58 | |
| PBT/Share (Rs.) | 11.12 | 9.35 | 7.45 | 6.05 | 7.38 | |
| Net Profit/Share (Rs.) | 8.44 | 6.95 | 5.85 | 4.56 | 5.83 | |
| NP After MI And SOA / Share (Rs.) | 8.40 | 6.92 | 5.88 | 4.56 | 5.83 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.83 | 23.37 | 21.52 | 20.17 | 25.16 | |
| PBIT Margin (%) | 19.65 | 19.96 | 18.72 | 17.16 | 22.53 | |
| PBT Margin (%) | 19.21 | 19.45 | 18.23 | 16.60 | 21.95 | |
| Net Profit Margin (%) | 14.58 | 14.46 | 14.32 | 12.53 | 17.33 | |
| NP After MI And SOA Margin (%) | 14.51 | 14.40 | 14.37 | 12.53 | 17.33 | |
| Return on Networth/Equity (%) | 15.42 | 15.19 | 15.25 | 15.53 | 26.90 | |
| Return on Capital Employed (%) | 18.66 | 18.97 | 18.75 | 19.93 | 33.35 | |
| Return on Assets (%) | 11.74 | 11.70 | 12.15 | 11.39 | 19.42 | |
| Total Debt/Equity (X) | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | |
| Asset Turnover Ratio (%) | 0.89 | 0.89 | 0.97 | 1.04 | 112.04 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.62 | 4.78 | 4.91 | 3.37 | 3.02 | |
| Quick Ratio (X) | 2.85 | 3.19 | 3.49 | 2.18 | 1.67 | |
| Inventory Turnover Ratio (X) | 3.58 | 1.21 | 1.35 | 1.30 | 3.40 | |
| Dividend Payout Ratio (NP) (%) | 7.14 | 7.22 | 3.81 | 5.47 | 1.71 | |
| Dividend Payout Ratio (CP) (%) | 5.86 | 5.84 | 3.19 | 4.41 | 1.49 | |
| Earnings Retention Ratio (%) | 92.86 | 92.78 | 96.19 | 94.53 | 98.29 | |
| Cash Earnings Retention Ratio (%) | 94.14 | 94.16 | 96.81 | 95.59 | 98.51 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 51.37 | 45.43 | 43.67 | 35.61 | 38.83 | |
| Interest Coverage Ratios (Post Tax) (%) | 51.37 | 45.43 | 43.67 | 35.61 | 38.83 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 9,417.36 | 6,244.01 | 2,540.86 | 1,577.14 | 1,869.83 | |
| EV/Net Operating Revenue (X) | 3.59 | 2.87 | 1.37 | 1.06 | 1.36 | |
| EV/EBITDA (X) | 15.72 | 12.27 | 6.37 | 5.24 | 5.40 | |
| MarketCap/Net Operating Revenue (X) | 3.84 | 3.15 | 1.72 | 1.25 | 1.49 | |
| Retention Ratios (%) | 92.85 | 92.77 | 96.18 | 94.52 | 98.28 | |
| Price/BV (X) | 4.08 | 3.33 | 1.83 | 1.55 | 2.31 | |
| Price/Net Operating Revenue | 3.84 | 3.15 | 1.72 | 1.25 | 1.49 | |
| Earnings Yield | 0.04 | 0.05 | 0.08 | 0.10 | 0.12 |
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
29.07.2025
07.07.2025
12.06.2025
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y
20.05.2025
Marksans Pharma Standalone March 2025 Net Sales at Rs 299.36 crore, up 32.93% Y-o-Y
28.02.2025
Marksans Pharma Consolidated December 2024 Net Sales at Rs 681.85 crore, up 16.33% Y-o-Y